Skip to content
Loop Biz – Lifestyle
Author:
Cyllene Therapeutics
Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion
July 7, 2026